Intravenous thrombolysis in acute ischemic stroke – to treat more and better!
Keywords:
effective, outcome, stroke, thrombolysisAbstract
Intravenous thrombolysis is the only evidence based effective treatment for ischemic stroke. There is an unrealized potential for increasing the rate of stroke patients undergoing specific treatment in Bulgaria and some other European countries. But efforts in this direction should not confuse the outcome of the applied therapy.
Qualitative indicators such as door-to-needle time and the degree of functional independence of the patients after thrombolysis should be subject to regulated analysis to ensure that specific treatment is available and effective for patients with acute stroke.
References
Boode, B., Welzen, V., Franke, C., van Oostenbrugge, R. Estimating the number of stroke patients eligible for thrombolytic treatment if delay could be avoided. Cerebrovasc Dis. 2007, 23, 294-298.
Christian, C.K., Gustafson, M.L., Betensky, R.A., Zinner, M.J. The volume-outcome relationship: don’t believe everything you see. World J Surg. 2005, 29, 1241-1244.
Fonarow, G.C., Smith, E.E., Reeves, M.J., Pan, W., Olson, D., Hernandez, A. F, Peterson, E.D., Schwamm, L.H. Hospital-level variation in mortality and rehospitalization for medicare beneficiaries with acute ischemic stroke. Stroke. 2011, 42, 159-66.
Halm, E.A., Lee, C., Chassin, M.R. Is volume related to outcome in health care? A systematic review and methodologic critique of the literature. Ann Intern Med. 2002, 137,6, 511-520.
Hannan, E.L., Wu, C., Ryan, T.J., Bennett, E., Culliford, A.T., Gold, P., Hartman, A., Isom, O.W., Jones, R.H., McNeil, B., Rose, E.A., Subramanian, V.A. Do hospitals and surgeons with higher coronary artery bypass graft surgery volumes still have lower riskadjusted mortality rates? Circulation. 2003, 108,7, 795-801.
Heuschmann, P.U., Kolominsky-Rabas, P.L., Misselwitz, B., Hermanek, P. Leffmann, C., Janzen, R.W., Rother, J., Buecker-Nott, H.J., Berger, K. Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: the German Stroke Registers Study Group. Arch Intern Med. 2004, 164,1761-1768.
Murray, G.D., Teasdale, M. The relationship between volume and health outcomes–a review. Scott Med J. 2006, 51,17-22.
Ogbu, U.C., Slobbe, L.C., Arah, O.A., de Bruin, A., Stronks, K., Westert, G.P. Hospital stroke volume and case-fatality revisited. Med Care. 2010, 48,2, 149-156.
Reed, S.D., Cramer, S.C., Blough, D.K., Meyer, K,. Jarvik, J.G. Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals. Stroke. 2001,32, 1832-1840.
Saposnik, G., Baibergenova, A., O’Donnell, M., Hill, M.D., Kapral, M.K., Hachinski, V. Hospital volume and stroke outcome: does it matter? Neurology. 2007, 69, 1142-1151.
Scherf, S., Limburg, M., Wimmers, R., Middelkoop, I., & Lingsma, H. (2016). Increase in national intravenous thrombolysis rates for ischaemic stroke between 2005 and 2012: is bigger better?. BMC neurology, 16, 53.
Wardlaw, J.M., Del Zoppo, G., Yamaguchi, T., Berge, E. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. 2003, 3.
Downloads
Published
How to Cite
Issue
Section
ARK
License
Copyright (c) 2021 Dobrinka Kalpachka, T. Sakelarova, R. Kalpachki
This work is licensed under a Creative Commons Attribution 4.0 International License.
